215 related articles for article (PubMed ID: 26059403)
1. Polyostotic osteolysis and hypophosphatemic rickets with elevated serum fibroblast growth factor 23: A case report.
Sato T; Muroya K; Asakura Y; Yachie A; Nishimura G; Aida N; Machida J; Tanaka Y; Hasegawa T; Adachi M
Am J Med Genet A; 2015 Oct; 167A(10):2430-4. PubMed ID: 26059403
[TBL] [Abstract][Full Text] [Related]
2. Expression of FGF23 is correlated with serum phosphate level in isolated fibrous dysplasia.
Kobayashi K; Imanishi Y; Koshiyama H; Miyauchi A; Wakasa K; Kawata T; Goto H; Ohashi H; Koyano HM; Mochizuki R; Miki T; Inaba M; Nishizawa Y
Life Sci; 2006 Apr; 78(20):2295-301. PubMed ID: 16337659
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological inhibition of fibroblast growth factor (FGF) receptor signaling ameliorates FGF23-mediated hypophosphatemic rickets.
Wöhrle S; Henninger C; Bonny O; Thuery A; Beluch N; Hynes NE; Guagnano V; Sellers WR; Hofmann F; Kneissel M; Graus Porta D
J Bone Miner Res; 2013 Apr; 28(4):899-911. PubMed ID: 23129509
[TBL] [Abstract][Full Text] [Related]
4. Hypophosphatemic Rickets with R179W Mutation in FGFR23 Gene - A Rare But Treatable Cause of Refractory Rickets.
Sandal S; Arora V; Verma IC
Indian J Pediatr; 2021 Jan; 88(1):61-63. PubMed ID: 32415663
[TBL] [Abstract][Full Text] [Related]
5. Genetic and clinical profile of patients with hypophosphatemic rickets.
Marik B; Bagga A; Sinha A; Khandelwal P; Hari P; Sharma A
Eur J Med Genet; 2022 Aug; 65(8):104540. PubMed ID: 35738466
[TBL] [Abstract][Full Text] [Related]
6. Osteocytes and the pathogenesis of hypophosphatemic rickets.
Yamazaki M; Michigami T
Front Endocrinol (Lausanne); 2022; 13():1005189. PubMed ID: 36246908
[TBL] [Abstract][Full Text] [Related]
7. [Updates on rickets and osteomalacia: FGF23-mediated hypophosphatemic rickets/osteomalacia].
Michigami T
Clin Calcium; 2013 Oct; 23(10):1429-35. PubMed ID: 24076640
[TBL] [Abstract][Full Text] [Related]
8. Seven novel and six de novo PHEX gene mutations in patients with hypophosphatemic rickets.
Li SS; Gu JM; Yu WJ; He JW; Fu WZ; Zhang ZL
Int J Mol Med; 2016 Dec; 38(6):1703-1714. PubMed ID: 27840894
[TBL] [Abstract][Full Text] [Related]
9. Mutational analysis of patients with FGF23-related hypophosphatemic rickets.
Kinoshita Y; Saito T; Shimizu Y; Hori M; Taguchi M; Igarashi T; Fukumoto S; Fujita T
Eur J Endocrinol; 2012 Aug; 167(2):165-72. PubMed ID: 22577109
[TBL] [Abstract][Full Text] [Related]
10. [Rickets/Osteomalacia. FGF23-related hypophosphatemic rickets/osteomalacia.].
Fukumoto S
Clin Calcium; 2018; 28(10):1313-1317. PubMed ID: 30269112
[TBL] [Abstract][Full Text] [Related]
11. Serum fibroblast growth factor 23 is a useful marker to distinguish vitamin D-deficient rickets from hypophosphatemic rickets.
Kubota T; Kitaoka T; Miura K; Fujiwara M; Ohata Y; Miyoshi Y; Yamamoto K; Takeyari S; Yamamoto T; Namba N; Ozono K
Horm Res Paediatr; 2014; 81(4):251-7. PubMed ID: 24577200
[TBL] [Abstract][Full Text] [Related]
12. Autosomal recessive hypophosphatemic rickets type 2 (ARHR2) due to ENPP1-deficiency.
Höppner J; Kornak U; Sinningen K; Rutsch F; Oheim R; Grasemann C
Bone; 2021 Dec; 153():116111. PubMed ID: 34252603
[TBL] [Abstract][Full Text] [Related]
13. Fibrous dysplasia, phosphate wasting and fibroblast growth factor 23.
Imel EA; Econs MJ
Pediatr Endocrinol Rev; 2007 Aug; 4 Suppl 4():434-9. PubMed ID: 17982392
[TBL] [Abstract][Full Text] [Related]
14. Patients with FGF23-related hypophosphatemic rickets/osteomalacia do not present with left ventricular hypertrophy.
Takashi Y; Kinoshita Y; Hori M; Ito N; Taguchi M; Fukumoto S
Endocr Res; 2017 May; 42(2):132-137. PubMed ID: 27754732
[TBL] [Abstract][Full Text] [Related]
15. Autosomal recessive hypophosphatemic rickets type 2; a novel mutation in the ENPP1 gene.
Bitkin EÇ; Aymelek HS
Turk J Pediatr; 2022; 64(3):585-591. PubMed ID: 35899574
[TBL] [Abstract][Full Text] [Related]
16. Mutational analysis of PHEX, FGF23 and CLCN5 in patients with hypophosphataemic rickets.
Guven A; Al-Rijjal RA; BinEssa HA; Dogan D; Kor Y; Zou M; Kaya N; Alenezi AF; Hancili S; Tarım Ö; Baitei EY; Kattan WE; Meyer BF; Shi Y
Clin Endocrinol (Oxf); 2017 Jul; 87(1):103-112. PubMed ID: 28383812
[TBL] [Abstract][Full Text] [Related]
17. C-Terminal Fibroblast Growth Factor-23 Levels in Non-Nutritional Hypophosphatemic Rickets.
Bharati J; Bhatia D; Khandelwal P; Gupta N; Sinha A; Khadgawat R; Hari P; Bagga A
Indian J Pediatr; 2019 Jun; 86(6):555-557. PubMed ID: 30835073
[TBL] [Abstract][Full Text] [Related]
18. Hypophosphatemic rickets: lessons from disrupted FGF23 control of phosphorus homeostasis.
Goldsweig BK; Carpenter TO
Curr Osteoporos Rep; 2015 Apr; 13(2):88-97. PubMed ID: 25620749
[TBL] [Abstract][Full Text] [Related]
19. [Value of serum fibroblast growth factor 23 in diagnosis of hypophosphatemic rickets in children].
Dong SS; Che RC; Zheng BX; Zhang AH; Wang CL; Bai M; Chen Y
Zhongguo Dang Dai Er Ke Za Zhi; 2023 Jul; 25(7):705-710. PubMed ID: 37529952
[TBL] [Abstract][Full Text] [Related]
20. Clinical and molecular heterogeneity in a large series of patients with hypophosphatemic rickets.
Capelli S; Donghi V; Maruca K; Vezzoli G; Corbetta S; Brandi ML; Mora S; Weber G
Bone; 2015 Oct; 79():143-9. PubMed ID: 26051471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
